Home / Search

Search

32 Search Results

Evaluation of anti-HCV-positive HCV RNA-negative patients: Is it a safe condition?

Mustafa Zanyar Akkuzu, Serkan Yaraş, Siad Mohammed Adam, Engin Altıntaş, Orhan Sezgin
Full Text PDF
DOI Link

The under water part of the iceberg: Anti-HCV positivity

Nilay Danis, Imre Altuglu, Ayse Arslan, Abdullah Murat Buyruk, Fulya Günsar, Aysin Zeytinoglu, Ulus Salih Akarca
Full Text PDF
DOI Link

Awareness of hepatitis C

Ömer Öztürk, Ilyas Tenlik, Derya Arı, Hale Gökcan, Sabite Kaçar, Meral Akdoğan
Full Text PDF
DOI Link

Sustained viral response to new HCV treatment (direct-acting antivirals) in the second year of treatment and evaluation of side effects

Seher Ayten Coskuner, Selma Tosun
Full Text PDF
DOI Link

Real-world efficacy, safety and clinical outcomes of ombitasvir/ paritaprevir/ ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: Turkey experience

Bilgehan Aygen, Neşe Demirtürk, Orhan Yıldız, Mustafa Kemal Çelen, Ilhami Çelik, Şener Barut, Onur Ural, Ayşe Batırel, Reşit Mıstık, Funda Şimşek, Ali Asan, Gülden Ersöz, Nesrin Türker, Hüseyin Bilgin, Çiğdem Ataman Hatipoğlu, Faruk Karakeçili, A A
Full Text PDF
DOI Link

Efficacy and safety of Paritaprevir/Ritonavir + Ombitasvir ± Dasabuvir ± Ribavirin in chronic hepatitis C patients with chronic renal failure

Fatih Güzelbulut, Ekrem Aslan, Ayça Gökçen Değirmenci Saltürk, Özgür Bahadır, Halil Şahin, Mevlüt Kiyak, Emine Kanatsız, Mustafa Keçeci
Full Text PDF
DOI Link

From cirrhosis to hepatocellular carcinoma: An investigation into hepatitis C viral oncogenesis using meta-analysis

Jihad Aljabban, Kamal Khorfan, Merve Gurakar, Nabeal Aljabban, Hussam Salhi, Maryam Panahiazar, Dexter Hadley, Behnam Saberi
Full Text PDF
DOI Link

Real-life results of treatment with ombitasvir, paritaprevir, dasabuvir, and ritonavir combination in patients with chronic renal failure infected with HCV in Turkey

Serkan Yaraş, Enver Üçbilek, Osman Özdoğan, Fehmi Ateş, Engin Altıntaş, Orhan Sezgin
Full Text PDF
DOI Link

Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience

Bilgehan Aygen, Neşe Demirtürk, Orhan Yıldız, Mustafa Kemal Çelen, İlhami Çelik, Şener Barut, Onur Ural, Ayşe Batırel, Reşit Mıstık, Funda Şimşek, Ali Asan, Gülden Ersöz, Nesrin Türker, Hüseyin Bilgin, Sami Kınıklı, Faruk Karakeçili, Gökmen Zararsız
Full Text PDF
DOI Link

A real-life evaluation of the effect of direct-acting antivirals in hemodialysis patients with chronic hepatitis C

Nurten Nur Aydın, Firdevs Aksoy, Ilknur Yavuz, Serap Iskender, Arzu Altuncekic Yildirim, Ilknur Esen Yıldız, Iftihar Koksal
Full Text PDF
DOI Link

Successfully treatment of chronic hepatitis C with direct-acting antiviral agents: a single center experience

Aysun Kartal, Dilara Turan Gökçe, Mesut Gümüşsoy, Mehmet Berk Örüncü, Necati Örmeci, Cihan Yurdaydın, Hasan Özkan, Ramazan Idilman
Full Text PDF
DOI Link

Insulin/high-density lipoprotein cholesterol ratio: A newly-discovered predictor of esophageal varices in patients with hepatitis C virus-related cirrhosis in the absence of diabetes mellitus

Khaled Nagy Elfayoumy, Mahmoud Saad Berengy, Tarek Emran
Full Text PDF
DOI Link

Direct acting antivirals are effective and safe in intravenous drug users with chronic HCV Preview of your abstract file infection: First report from Turkey

Fehmi Tabak, Behice Kurtaran, Esra Zerdali, Selma Tosun, Şaban Esen, Nefie Çuvalcı Öztoprak, Kamuran Türker, Nagehan Didem Sarı, Yusuf Önlen, Tansu Yamazhan, Kenan Hızel, Hepcturkey Study Group
Full Text PDF
DOI Link

Efficacy and Safety of Direct-Acting Antivirals in Patients with Hepatitis C Infection: Nationwide Real-life Data from Türkiye

Alper Gunduz, Nefise Çuvalcı Öztoprak, Nagehan Didem Sarı, Behice Kurtaran, Yusuf Önlen, Ebubekir Senates, Esra Zerdali, Hasan Karsen, Ayse Batırel, Rıdvan Kara Ali, Rahmet Güner, Tansu Yamazhan, Sukran Kose, Nurettin Erben, Nevin Ince, İftihar Köksal, Figen Sarıgül Yıldırım, Gulsen Yoruk, Suheyla Komur, Tayibe Bal, Sibel Kaya, Şaban Esen, Özgür Günal, Ilknur Esen Yıldız, Dilara Inan, Şener Barut, Mustafa Namıduru, Selma Tosun, Kamuran Türker, Alper Sener, Kenan Hızel, Nurcan Baykam, Fazilet Duygu, Esragül Akıncı, Güray Can, Ulku User, Hanefi Cem Gül, Ayhan Akbulut, Güven Çelebi, Mahmut Sünnetçioğlu, Oğuz Karabay, Hayat Kumbasar Karaosmanoğlu, Fatma Sırmatel, Fehmi Tabak
Full Text PDF
DOI Link

Effect of sofosbuvir on QT interval and other electrocardiography (ECG) findings in patients with HCV related decompase cirrhosis

Mehmet Demir
Full Text PDF
DOI Link

Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey

Esra Çınar Tanrıverdi, Zülal Özkurt, Berrin Göktuğ Kadıoğlu, Handan Alay, Okşan Çalıkoğlu, Özlem Koca, Zeynep Kamalak
Full Text PDF
DOI Link

Direct-acting antiviral drugs used ın the treatment of HCV Increase cholesterol levels

Osman Ozdogan, Serkan Yaras, Enver Ucbilek, Fehmi Ates, Orhan Sezgin, Engin Altintas
Full Text PDF
DOI Link

Efficiency and safety of direct-acting antiviral in cirrhotic hepatitis C infection patients: Real-life data from Turkey

Yeşim Taşova, Tansu Yamazhan, Şaban Esen, Nefise Çuvalcı Öztoprak, Yusuf Önlen, Nagehan Didem Sarı, İlknur Esen Yıldız, Dilara İnan, Esra Zerdali, Rahmet Güner, Şener Barut, Hayat Kumbasar Karaosmanoğlu, Sibel Kaya, Nevin İnce, İlyas Dökmetaş, Fehmi Tabak, Hepcturkey Study Group
Full Text PDF
DOI Link

Prevalence of the potential drug-drug interactions between pangenotypic direct-acting antivirals and the concomitant medication with patients with chronic hepatitis C virus infection

Antoni Sicras Mainar, Sabahattin Kaymakoglu
Full Text PDF
DOI Link

Real-Life Experience of Hepatitis C Treatment with Direct-Acting Antivirals in Genotypes 2 and 3

Sibel Yıldız Kaya, Behice Kurtaran, Nefise Öztoprak Çuvalcı, Yusuf Önlen, Mehmet Reşat Ceylan, Esra Zerdali, Nagehan Didem Sarı, Ahsen Öncül, Nurettin Erben, Ayse Batirel, Dilara İnan, Süheyla Kömür, Figen Sarıgül Yıldırım, Hasibullah Yaqoobi, Ferit Kuscu, Rahmet Guner, Fehmi Tabak, Hep-C Türkiye Study Group
Full Text PDF
DOI Link

Investigation of the factors affecting the response of treatment ın patients treated with oral direct acting antiviral agents

Yucel Ustundag, Yonca Yilmaz Urun, Aydin Seref Koksal, Oguz Karabay, Bilal Toka, Ahmet Tarik Eminler, Ertugrul Guclu, Erkan Parlak
Full Text PDF
DOI Link

Paritaprevir+Ritonavir+Ombitasvir+Dasabuvir±Ribavirin treatment in HCV infected chronic hemodialysis patients: A single center experience

Nilay Danis, Husnu Pullukcu, Tansu Yamazhan, Galip Ersoz, Nalan Gülsen Unal, Fulya Gunsar, Ilker Turan, Zeki Karasu, Ulus Salih Akarca
Full Text PDF
DOI Link

Clinical characteristics of hepatocellular carcinoma: Results from central Anatolian region of Turkey

Gülten Can Sezgin, Demet Çoşkun, Alper Yurci, Güven Kahriman, Ömer Özbakır, Kadri Güven, Mevlüt Başkol, Mehmet Yücesoy, Kemal Deniz, Şebnem Gürsoy
Full Text PDF
DOI Link

Daclatasvir plus sofosbuvir regimen sheds promising light on future hepatitis C virus genotype 3 therapies

Ali Murat Kahveci, Veysel Tahan
Full Text PDF
DOI Link

Case Report: Drug-induced liver injury mimicking hypereosinophilic syndrome

Suna Yapali, Serap Yucel, Nevin Sariguzel, Murat Saruç, Hakan Umit Unal, Arzu Tiftikci, Eser Kutsal, Oguz Fatih Onder, Gurhan Sisman, Cem Aygun, Ozdal Ersoy, Safak Kiziltas, Bahattin Cicek, Nurdan Tozun
Full Text PDF
DOI Link

Changing in the etiologies and the presentation charactheristics in hepatocellular carcinoma. A single center experience in western Turkey

Seymur Aslanov, Murat Akyıldız, İlker Turan, Nilay Danış, Galip Ersöz, Fulya Günşar, Ömer Özütemiz, Ulus Salih Akarca
Full Text PDF
DOI Link

Efficiency and safety of direct acting antivirals in chronic hepatitis C patients ınfected with genotype 2 and 3 in Turkey

Behice Kurtaran, Figen Sarıgül, Mehmet Çabalak, Sibel Kaya, Nagehan Didem Sarı, Hasan Karsen, Esra Zerdali, Rahmet Güner, Kamuran Türker, Nevin Ince, Fehmi Tabak, Hepcturkey Study Group
Full Text PDF
DOI Link

Characteristics of Newly Diagnosed Hepatocellular Carcinoma Patients Across Turkey: Prospective Multicenter Observational 3K Registry Study

Ulus Salih Akarca, Belkis Unsal, Orhan Sezgin, Kendal Yalcin, Meral Akdogan, Can Gonen, Feyza Gunduz, Seren Ozenirler, Abdullah Sonsuz, Dinc Dincer, Salim Basol Tekin, Idris Yucel, Hakan Akbulut, Canan Alkım, Ozgur Ozyilkan, Arzu Baygul, Zeynep Merve Cevik, Ramazan Idilman
Full Text PDF
DOI Link

Covering the Cover

Bilal Toka
Full Text PDF
DOI Link

Sofosbuvir and Velpatasvir: A complete pan-genotypic treatment for HCV patients

Alp Serhat Kahveci, Veysel Tahan
Full Text PDF
DOI Link

Nonsirotic chronic hepatitis B presenting with hepatocellular carcinoma: a case report

Ahmet Uyanikoglu, Meliha Ozkutlu
Full Text PDF
DOI Link

Development of hypocalcemia with telaprevir-based triple treatment in a case of genotype 1 chronic hepatitis C

Ebubekir Şenateş, Yaşar Çolak, Atakan Yeşil, İlyas Tuncer
Full Text PDF
DOI Link
1 - 32 of 32 items